The 2022 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
An Equity, Diversity and Inclusion Action Plan for the RI-MUHC
The plan prioritizes six groups traditionally underrepresented in research
Gabriella Gobbi honoured by the International College of Neuropsychopharmacology
An RI-MUHC researcher with global outreach, Dr. Gobbi is dedicated to advancing the science for mental health
Quebec study on long COVID seeking participants
Purpose is to understand post-COVID symptom evolution and impact on patients’ lives
Summer Student Research Day returns to the RI-MUHC
A diverse group of young research trainees present their summer projects
Leonard Levin receives prestigious international ophthalmology award
Crossing borders between laboratory research and clinical applications
Three Tier-1 Canada Research Chairs for RI-MUHC researchers
Drs. Gabriella Gobbi, Madhukar Pai and Cécile Rousseau are part of the McGill University cohort of nine new and renewed Canada Research Chairs
Another secret of fibromyalgia discovered in the microbiome
Researchers find alterations in gut bacteria and blood bile acids of women with fibromyalgia associated with the severity of their symptoms...
The unexpected role of chloride channels in a rare neurological disorder
A new study finds mutations affecting the chloride channel of a glutamate transport protein in a rare disorder...
LSD, a future antianxiety pill?
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety